Skip to main content
. 2020 Oct 19;2020(10):CD012859. doi: 10.1002/14651858.CD012859.pub2

Kwak 2019.

Methods Randomized controlled trial
Participants Patients undergoing breast surgery
Interventions Dexmedetomidine 0.5 µg/kg or combination of dexmedetomidine 0.5 µg/kg and dexamethasone 5 mg at 30 minutes before end of surgery
Outcomes PONV
Notes Study identified in search update; data will be included in next update of the review